Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06268704 · ClinicalTrials.gov registry record · Phase 4
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
A Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis, sponsored by University of New Mexi.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 230
- Enrollment target
- 1
- Study location
NCT06268704: Recruiting Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis, sponsored by University of New Mexi.
NCT06268704 is a Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 230 participants, above the 137-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06268704, a Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.
Primary Outcome
Numeric pain rating score is an 11 point scale (0-10) filled out on a form indicating the degree to which the patient experiences pain to assess efficacy of the injection. In this scale a 0, the minimum score, indicates no pain at all with a 10, the maximum score, being the worst pain imaginable. In this study a 50% or greater reduction in numeric pain rating score is considered a successful outcome while failure to achieve at least a 50% improvement as compared to their numeric pain rating scor
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Methylprednisolone
- DRUG 2% Lidocaine HCl Injection
Study Locations (1)
New Mexico
- University of New Mexico Hospital - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2024-03-27 |
| Est. Completion | 2027-05-01 |
| Phase | Phase 4 |
What NCT06268704 shows while recruiting
NCT06268704 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, above the 137-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (68% higher).
The record links to 2 conditions, with Sacroiliac Joint Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.
NCT06268704 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT06268704 about?
NCT06268704 is a clinical study titled "Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection". This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.
What is the current status of trial NCT06268704?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 230 participants. The study started on 2024-03-27. Estimated completion is 2027-05-01.
What conditions does trial NCT06268704 study?
This clinical trial studies the following conditions: Sacroiliac Joint Dysfunction, Sacro-Iliac Spondylosis.
What interventions are being tested in trial NCT06268704?
The interventions under investigation include: Dexamethasone (DRUG), Methylprednisolone (DRUG), 2% Lidocaine HCl Injection (DRUG).
Who is sponsoring clinical trial NCT06268704?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06268704 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliac Joint Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI